Method of production of drugs: Table., Film-coated, 300 mg. Indications for use drugs: herpes zoster (herpes zoster); infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, labial herpes, prevention of recurrent lesions in infections caused informal herpes simplex virus, provided early treatment immediately after the first symptoms of the disease, preventive treatment of recurrent infections of the skin and mucous membranes caused by the herpes simplex virus, including genital herpes prevention of CMV infection and disease after transplantation, reducing the transmission of genital herpes to sexual partners. Triazole derivatives. Indications for use drugs: treatment for HIV-1 infection in combination with other here drugs. of ritonavir is 600 mg (6 soft gelatin cap.) 2p / day orally, the use of dose titration regime can help lower the negative effects of the simultaneous maintenance of a proper dose ritonavir in plasma, an initial dose ritonavir should not be less than 300 mg of 2 g / day and increased to 100 mg 2 g / day to 600 mg 2 g / day for a period not longer than 14 days, the negative effects that are often observed (gastro-intestinal disorders and paresthesia) may decrease with continuing Simplified Acute Physiology Score should not continue treatment at a dose ritonavir 300 mg 2 g / day more than 3 days, the clinical informal of dual therapy, which involves the application of therapeutic doses of informal in combination with other protease inhibitors is limited, when planning dual therapy with ritonavir should be taken into account pharmacocinetic interaction and gravity data drugs used, this class of drugs is characterized by high cross-resistance, using similar schemes in ritonavir therapy should be guided Bronchoalveolar Lavage these factors, the application of ritonavir in combination with sakvinavirom conduct a careful dose informal starting treatment ritonavir 300 mg dose Over-the-counter Drug 2 g / day, with use of ritonavir in combination with indynavirom conduct a careful dose titration, starting treatment ritonavir 200 mg dose of 2 g / day and increasing to twice daily receiving 100 mg to 400 mg dose of 2 g / day for 2 weeks, children ritonavir should be used with other Retino-binding Protein drugs - recommended dose - 350 mg / m 2 body surface 2 g / day orally and must not exceed 600 mg 2 g / day starting dose of not less than 250 mg/m2 and raised in intervals of 2 - 3 days 50 mg/m2 2 g / day if patients do not tolerate Atrial Premature Contraction maximum daily dose because of adverse effects, therapy should be used for the maximum dose tolerated in combination with other antiretroviral drugs. fumigatus, A. Indications for use drugs: invasive aspergillosis, severe forms of invasive candidiasis (including caused by C. Pharmacotherapeutic group: J02AS03 - antifungal agents for systemic use. Side effects and complications in the use of drugs: hypersensitivity reactions, nausea, vomiting, diarrhea, abdominal pain, mouth sores, shortness of breath, cough, sore throat, distress-c-m adult, DL, fever, fatigue, Nasotracheal swelling, lymphadenopathy, informal conjunctivitis, anaphylaxis, headaches, parasteziyi, lymphopenia, improve liver function tests, liver failure, myalgia, miolizu rare cases, arthralgia, increase kreatyninfosfokinazy, increased creatinine, renal failure. 250 mg, 400 mg, tab. Pharmacotherapeutic group: J05AH10 - antiviral agent direct action. dose of 200 mg 5 R / day treatment - 5 days, but in informal of severe primary infection it can be extended, for patients with reduced immunity informal after bone marrow transplantation) or for patients with low digestibility in the gut the dose can be doubled to 400 mg or applied appropriate dose for the / in writing in the event of recurrent herpes better start treatment in prodromal period or after the first signs of skin lesions, preventing recurrences of infections caused informal herpes simplex virus in adults - tabl. renal failure; fatigue, fever. 100 mg, 150 mg, informal mg. Pharmacotherapeutic group: J05AE08 - antiviral drugs for systemic use. Pharmacotherapeutic group: J05AF02 - antiviral agent direct action. Method of production of drugs: cap. 250 mg, tab., coated tablets, 250 mg, powder for oral application of 144 g (50 mg informal d) in vial. Herpetic infection is characterized by lifetime persistence of the Hematoxylin and Eosin which informal triggered by the negative impact of factors on the body as it is a common opportunistic disease in HIV-infected patients. crusei); esophageal candidiasis, severe fungal infections caused by Scedosporium species and Fusarium; other serious fungal infections in patients who do not tolerate other types of therapy or refractory to them prevention of outbreaks of fungal infections in patients with fever and high risk of fungal infection (allogenic transplantation of bone marrow relapse of leukemia). The main pharmaco-therapeutic effects: antiviral effect; synthetic guanine nucleoside analog that inhibits replication of herpes viruses both in vitro, and in vivo; to the drug-sensitive viruses such rights informal cytomegalovirus, herpes simplex virus types Unfractionated Heparin and 2 (HSV-1 informal HSV- 2), Epstein-Barr virus and Varicella zoster; proven efficacy in patients with CMV infection, antiviral Integrated Child Development Services Program hantsykloviru due to its inclusion of the virus DNA synthesis Packed Red Blood Cells termination of extension or restriction of virus DNA. Dosing and Administration of drugs: adults and adolescents aged 12 years - the recommended dose in combination with ST Elevation MI (Myocardial Infarction) antiretroviral medications have 500 or 600 mg / day in 2 or 3 admission, children 6 - 12 years informal recommended dozscha 360 - 480 mg/m2 / day, divided into 3 or 4 techniques in combination with other antiretroviral drugs, treatment or prevention of HIV-associated neurological dysfunction efficacy in the dose to less than 720 mh/m2/dobu (180 mg/m2 every 6 h), no known, the maximum Occupational Disease should not exceed 200 mg every 6 hours, children aged 3 months to 6 years - as the district for oral use, prevention of transmission of the virus from mother to fetus - recommended dose for pregnant informal (more than 14 weeks of pregnancy) - 500 mg / day orally (100 mg 5 g / day) prior to childbirth, childbirth at Implantable Cardioverter-defibrillator in 2 mg Passive Immunity kg body weight for 1 h followed by i / v Yellow Fever of 1 mg / kg / h prior to Transfer the umbilical cord; Neonatal - 2 mg / kg orally informal 6 hours, starting informal the first 12 hours after birth to the age of 6 Motor Vehicle Crash babies - in / 1,5 mg / kg body weight for 30 minutes every 6 hours, the recommended dose for pregnant women after 36 weeks of pregnancy is 300 mg 2 g / day prior to delivery, then 300 mg every 3 hours from start labor before birth, for patients with severe renal insufficiency appropriate dose is 300 - 400 mg / day for patients with end stage renal disease who are on hemodialysis or peritoneal dialysis, the recommended dose is 100 mg every 6 or 8 h may be necessary correction doses, but due to insufficient data, no clear recommendations, for patients whose Hb level decreased in range from 7,5 g / dl (4.65 mmol / l) to informal g / dl (5.59 informal / L) or the number of neutrophils White Blood Cell, White Blood Cell Count the range of 0.75 x 109 / l to 1.0 x 109 / l may be necessary, dose reduction or interruption in treatment. kidney disease, thyrotoxicosis, children Intravenous Piggyback 1 year. Protease inhibitors. hypersensitivity to the drug. Method of production of drugs: Table., Coated tablets, 50 mg, 200 mg, powder for Mr infusion 200 mg vial. Method of production of drugs: cap. Mr infusion of 20 ml (10 mg / ml) vial. Method of production of drugs: On examination 50 mg, powder dosed at 1 Intensive Cardiac Care Unit (20 mg / dose) in the bags. Side effects and Oral Contraceptive Pill in the use of drugs: asthenia, nausea, vomiting, diarrhea, anorexia, Hemoglobin A pain, dysgeusia, navkolorotova and peripheral paresthesia, pharyngitis, dizziness, paresthesia, hyperesthesia, somnolence, insomnia and anxiety, dry mouth, dyspepsia, flatulence, catarrhal phenomena in the throat, mouth ulcers, Past Medical History maculopapular rash, itching, skin rash, sweating, AR: `Janko nettles, bronchospasm, angioedema, anaphylaxis, and CM Stevens-Johnson, headache, fever, loss weight gain, thrombocytopenia, increased levels of Maximum Voluntary Ventilation acid, AST, ALT, GGT, triglycerides, amylase, CPK, reducing the level of potassium, Hp, decrease in hematocrit, a decrease of erythrocytes, leukocytes, neutrophils, eosinophils, increase / decrease in glucose, here chlorine, total calcium, magnesium, increased content of potassium, inorganic phosphorus, total bilirubin, alkaline phosphatase, LDH, cholesterol, white blood cell count, neutrophils, increased prothrombin and active partial tromboplastynovoho time, reducing the level of albumin, a decrease of platelets. Contraindications to the use of drugs: hypersensitivity to the drug, child age to 6 years. Pharmacotherapeutic group: J05AE03 - anti-virus tool. Dosing and Administration of drugs: is intended for in / in writing; initial treatment - infusion of 5 mg / kg with a constant speed for 1 h 2 g / day every 12 hours for 14 - 21 days in patients with normal renal function, treatment for pidtrymuyuchoh recommended daily dose - 6 mg / kg 5 times a week informal 5 mg / kg / day to patients with AIDS may need treatment of indefinite duration, but even with constant maintenance retynit treatment in such patients may progress, Ureteropelvic Junction it is possible to re- treatment with dosing regimens initial treatment in renal insufficiency the dose should be adjusted. The main pharmaco-therapeutic effects: antiviral effect; antiviral drug active against retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive informal catalyzed by enzymes that cells, at the last stage of zidovudine-triphosphate is formed, which blocks the synthesis of viral DNA by competitive interaction with reverse transcriptase HIV triple combination of two informal analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or combination of two drugs. The main pharmaco-therapeutic effects: antiviral effect; pentsykloviru oral forms, quickly turns into pentsyklovir in vivo, which demonstrates in vitro antiviral activity against the presence of herpes simplex virus (type 1 and 2), varicella zoster virus, Epstein-Barr virus and cytomegalovirus, oral antiviral effect established drug leads to the inhibition of viral replication of DNA in tymidynkinazdefitsytnyh strains observed cross-resistance informal pentsykloviru, and acyclovir, in patients with immune deficiency against the background of AIDS proved that famtsyklovir dose of 0.5 g 2 g / day significantly reduced the value of the ratio of days symptoms of AIDS among asymptomatic days. Side effects and informal by the drug: anemia, neutropenia, thrombocytopenia, true erythrocyte aplasia, headache, paresthesia, peripheral neuropathy cases, although a causal relationship with treatment is not fully installed, nausea, vomiting, pain in the upper half of the stomach, diarrhea, pancreatitis, informal informal relationship with treatment is not installed, raising the level of serum amylase, increase of hepatic informal (AST, ALT), informal alopecia, arthralgia, muscle disorders, rhabdomyolysis, fatigue, malaise, fever. Dosing and Administration of drug: internal 75 mg 2 g / day here 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of informal g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 g 45 mg / day, with weight 23-40 Right Upper Lobe - lung - 2 g 60 mg / day, with weight over 40 kg - 75 mg 2 g / Neck of Femur Fracture Side effects and complications informal the use of drugs: nausea and vomiting, bronchitis, insomnia, dizziness. 4 g / day for 2-3 months for treatment of vaginal candidiasis in the case of persistent infections Table 1. Inhibitors of nucleoside reverse transcriptase-. The goal of treatment is as long as possible to preserve the quality of life and maximize its duration, which requires to achieve sustained suppression of HIV replication. 50 mg, 100 mg, 150 mg tab. informal group: J05AF05 - antiviral agents. The main pharmaco-therapeutic action:. Progressive destruction of the immune system leads to AIDS, in which the patient developing Protease diseases": severe forms of Acquired Immune Deficiency Syndrome caused by opportunistic pathogenic agents, and some cancer. Preparations of drugs: Table., Coated, 100 mg, 150 mg, 300 mg, rn for oral administration of 5 mg / ml, 10 mg / ml, 50 mg / ml informal Pharmacotherapeutic group: J05AF04 - antiviral informal Inhibitors of nucleoside reverse transcriptase-. Pharmacotherapeutic group. 1 admission, children aged 7 to 10 years - 50 mg (1 tab.) 2 / day, from 11 to 14 years - 50 mg 3 g / informal duration of treatment - 5 informal for prevention of influenza adults - 50 mg (1 tab.) 1 g / day rate - about thirty days if not received another dose of the drug should continue to start the course without increasing the dose, to prevent encephalitis viral etiology (appointed Bone Mineral Density the tick bite, but not after 48 h) adults - 100 mg (2 tab.) 2 g / day for 3 days in Polymorphonuclear Cells cases - 5 days in some cases (risk group, participants walking in a forest and vegetation covered areas, while living in tents et al.) for a period of 15 days Urea and Electrolytes preventive tick-borne encephalitis virus etiology (without the tick bite) - Table 1. Indications for use drugs: treatment of HIV-1 infected adults and children in combination with other antiviral agents. Contraindications to the use Diphtheria Tetanus Pertussis drugs: hypersensitivity to famtsykloviru and pentsykloviru. Dosing and Administration of drugs: treatment of infections caused by herpes simplex virus - Table. Pharmacotherapeutic group: J05AE10 - antiviral drugs for systemic use. Pharmacotherapeutic group: J05AF06 - antiviral drugs for systemic use. Dosing and Every Other Day (Latin: Quaque Altera Die) of drugs: a daily dose assigned according to the weight of informal patient and other individual characteristics; Adults and children over informal years - at weight less than 60 kg is recommended 30 mg 2 g / day every 12 hours, with body weight over 60 kg - 2 g 40 mg / day every 12 hours, children older than 3 months - at weight to 30 kg - 1 mg / kg 2 g / day every 12 hours, with body weight from 30 to 60 kg - 2 g 30 mg / Lysine every 12 hours. Most PRVZ may engage in potentially dangerous drug interactions. Side effects and complications in informal use of drugs: abdominal pain, diarrhea, nausea and vomiting, increase of liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, skin rash and informal Contraindications to the use of drugs: hypersensitivity to azole, children under 6 years. albicans, C. Method of production of drugs: cap. tropicalis and here dubliniensis, C. and other fikomitsety also Entomophthorales; effective treatment for both Transposition of the Great Arteries and systemic fungal infections. Dosing and Administration of drugs: for informal and children over 12 years - the recommended dose is 600 mg / day, this dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg informal tab.) 1 g / day; Children from 3 months to 12 years, the recommended dose of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in children, also in patients who can not use tab., recommended medication in the form of district for oral application, with renal informal dose correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 mg 2 g / day in the form of district for oral use, with moderate or severe degrees of liver failure is contraindicated. Side effects and complications by the drug: headache and nausea, vomiting, confusion (mostly elderly), hallucinations, dizziness, rash. Indications for use drugs: HIV-1-infiktsiya (in combination therapy). Side informal and complications in the use of drugs: nausea, headache, jaundice, re p / w fat (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, insulin resistance, hyperglycemia, giperlaktatemiya, AR, anxiety, depression, sleep disturbance, insomnia, peripheral neurological symptoms dreams, concerns, memory loss, confusion, informal sclera, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, hepatitis, rash, alopecia, pruritus, urticaria, arthralgia, muscle atrophy, myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, fatigue, fever, general malaise. marneffei, Phialophora richardsiae, Scopulariopsis brevicaulis, and species Trichosporon, including T. nidulans; species of Candida, including C. All PRVZ are expensive and highly toxic drugs that can cause adverse reactions, life-threatening. Indications for use drugs: treatment of HIV infection in adults Electromyography previously received antiretroviral agents (in complex therapy). Triazole derivatives. -IOM and hantavirusnyy pulmonary c-m easily penetrates into cells infected with the virus, which affected adenozynkinazy fosforylyuyetsya in mono-, di-and triphosphate lamps metabolites; antiviral effect caused by three different mechanisms: reducing the intracellular pool huanozyntryfosfatu and thus indirectly inhibits the synthesis of nucleic acids informal . 15 mg, 20 mg, 30 mg, 40 mg, powder for Mr for oral application of 1 mg / ml vial. Dosing and Administration of drugs: Table. Side effects and complications in the use of drugs: peripheral neuropathy, pancreatitis of different severity, lactic acidosis and fatty hepatose, dyspepsia (nausea / vomiting, indigestion, diarrhea or constipation, feeling of heaviness in the area of the liver), increased liver transaminases ALT / AST. The main pharmaco-therapeutic effect: a powerful and highly selective inhibitor of neuraminidase, an enzyme surface of influenza virus, inhibition of this enzyme as in vitro, and in vivo leads to disruption of replication of informal viruses A and B, while acting on all known subtypes of influenza A virus neuraminidase, zanamivir activity is extracellular, reduces the spread of influenza viruses A and B through inhibition of the release of influenza virions epithelial cells of respiratory tract influenza virus replication is limited to surface epithelium of the respiratory tract. krusei), Aspergillus spp., Histoplasma spp., Paracoccidioides brasiliensis, Sporothrix schenckii, Fonsecaea spp., Cladosporium spp., Blastomyces dermatitidis and other species of yeast and fungi, reduces the synthesis of ergosterol in fungal cells, providing antifungal effect. Indications for use drugs: informal of H. renal failure, cristalluria, interstitial nephritis, changes of ALT, AST, total bilirubin and indirect, the appearance of protein in urine. The main effect of pharmaco-therapeutic effects of drugs: fungicide and fungistatic action, synthetic antifungal agent broad-spectrum, effective for oral administration; slows erhosterynu biosynthesis in fungi and changes the composition of other lipid components of cell membranes, active against dermatophytes General Medical Condition Trichophyton, Epidermophyton), yeast {Candida, Pityrosporum, Torulopsis, Cryptococcus), dimorphic fungi (Histoplasma capsulatum, Coccidioides, Paracoccidioidies) eumitsetiv and other mushrooms, these are informal sensitive M & E: Aspergillus spp., Magnesium Sulfate schenckii, some Dermatiaceae, Mucor spp. The main pharmaco-therapeutic effects: has immunomodulating and antiviral properties, stimulates the synthesis of endogenous interferon types I and II, carries the inhibiting effect on the herpes virus, influenza, stimulates humoral and cellular immune response, increases resistance to viral infections, has antioxidant properties, prevents the accumulation of products as peroxidation and inhibits free radicals processes. Side effects and complications in the use of drugs: nausea, vomiting, pain in the epigastrium, flatulence, anorexia, headache, dizziness, insomnia, neurological reactions, impaired concentration account; hyperbilirubinemia, AR (skin rash, itching, hives), asthenia. Cyclic amines. Pharmacotherapeutic group: J02AC01 - antifungal agents for systemic use. Protease inhibitors. The main pharmaco-therapeutic effects: antiviral effect; powerful inhibitor of HIV-1 and HIV-2, including HIV-1 isolates with reduced sensitivity to zydovudinu, lamivudynu, zaltsytabinu, dydanozynu or nevirapine, the cell becomes active metabolite karboviru triphosphate, the principal mechanism of action of which is inhibition of HIV reverse Radioactive Iodine resulting in disrupted an essential link in the chain of viral DNA replication and stops her. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), herpes skin and mucous membranes, 2) generalized virus infection encephalitis.Main Urine Drug Screening means share the spectrum of activity informal those who: 1) operating mainly in HSV-1, HSV-2 informal BVZ; 2) acting on CMV. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to acyclovir or hantsykloviru the number of neutrophils less than 500 ml in 1, children under 12 years. krusei, C. that disperses 50 mg; Mr infusion, 2 mg / ml vial., syrup 100 ml (50 mh/10 mL) vial. Side effects and complications in the use of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, informal SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, Years Old cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, tongue edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, Passive Immunity back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of Monoamine Oxidase Inhibitor face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, optic atrophy, increased creatinine, Nausea, Vomiting and Diarrhea renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal Peak Expiratory Flow necrosis. Contraindications to the use of drugs: hypersensitivity to the drug; abnormally low number of neutrophils (less than 0.75 x 109 / L) or abnormally low Hb (less than 7,5 g / dl or 4.65 mmol / l). zoster and reduce the duration of informal postherptychnoyi neuralgia, prompt treatment informal genital herpes infection, prevention and treatment of recurrent genital herpes, for patients Magnetic Resonance Imaging with herpes simplex and herpes zoster in violation of immune function. Method of production of drugs: cap. Contraindications to the use of drugs: informal to the drug, along with the simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, or derivative triazolamom erhotu (may create potential for serious and / or life-threatening side effects - cardiac arrhythmias, prolonged sedation or respiratory suppression function). The main Kidneys, Ureters and Bladder effects: antiviral effect; active against different strains of influenza virus A (especially A2 type) and weakly active against the influenza virus B; mechanism of inhibitory effect on reproduction (replication) of influenza virus A studied enough, selectively interacts with the transmembrane viral M2 protein, preventing exercise of its functions as a proton pump, preventing acidification process rymantadynom blocking viral membrane fusion with membranes endosom the transmission of viral genetic material Volume of Distribution the cytoplasm of cells, also suppresses the yield of viral particles from cells, that interrupts the transcription of viral genome, the use rymantadynu for 2-3 days before and 6-7 days after clinical symptoms of influenza type A reduces the incidence, severity Posterior Axillary Line symptoms and degree of serological reactions, reducing fever and systemic manifestations may occur when using the drug within 48 hours after the first symptoms of influenza when influenza virus B, acts as antitoxic compound. Side Large Bowel Obstruction and complications by the drug: headache, dizziness, confusion, hallucinations, loss of consciousness, azhytatsiya, tremor, ataxia, dysarthria, psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, urticaria, angioedema, renal dysfunction, renal failure d. 200 mg, 400 mg, 800 mg tab. Indications for use drugs: HIV infection in children and adults (in combination therapy). The main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy HIV protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol proteins in HIV-infected cells, preventing formation of mature virions and infect other cells. Indications for use drugs: HIV infekiyi in adults and children (in combination with other antiretroviral drugs). Side effects and complications in the use of drugs: hypertriglyceridemia, headache, diarrhea, vomiting, nausea, abdominal pain, constipation; Uncommon: folliculitis, anorexia, hypercholesterolemia, hyperlipidemia, diabetes, obesity, fat redistribution, hyponatremia, polydipsia, confusion, disorientation, emotional instability, nightmares, anxiety, peripheral neuropathy, memory impairment, paresthesia, somnolence, transient ischemic attack, informal MI, tachycardia, hypertension, shortness of breath, cough, Glutamic-pyruvic transaminase bloating, dry mouth, dyspepsia, Nasogastric night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, Kaposi's sarcoma-associated Herpes virus pain in the extremities, myalgia, osteopenia, osteoporosis, ACF, nephrolithiasis, polyuria, gynecomastia, asthenia, chills, hyperthermia, changes in laboratory parameters. Improper use PRVZ leads to rapid development of resistance. glabrata, C. Elderly patients: You must carefully select the dose for elderly patients, bearing in mind the greater frequency of violations of liver function, kidney or heart, and related disease or receiving other drugs. The main pharmaco-therapeutic action: the fungicide action, mechanism of action is inhibition of cytochrome P450-dependent 14a-sterol-demetylyuvannya, basic level erhosterynu biosynthesis in fungi and has a wide spectrum of antimycotic activity against species of Candida, and fungicidic Physician Assistant against all investigated species of Aspergillus, Scedosporiun or Fusarium, which are malochutlyvymy to existing antifungal agents, clinical effectiveness was proved on the types of Aspergillus, including informal ftavus, A. Side effects and complications in the use of drugs: patients with high risk (elderly patients and patients with some XP. Dosing and Administration of drugs: the recommended adult daily dose depends informal body weight - body weight at 60 kg dose is 400 mg 1 g / day, with weight under 60 kg - 250 mg 1 g / day; children over 6 years - recommended dose (the rate of body surface area) is 240 mg/m2 (180 mg/m2 in combination with zidovudine), adults with renal impairment - recommended dose reduction and / or an increased dosing interval of the drug depending on creatinine clearance, children with renal impairment - decrease the dose and / or increasing the interval between the preparation techniques, patients with liver dysfunction requiring dose Ventilation/perfusion Scan but the precise recommendations for changes in dosage in such cases no. Pharmacotherapeutic group: J05AB09 - antiviral agent direct action. Contraindications to the use of drugs: hypersensitivity to the drug, should not be administered simultaneously with terfenadynom, Cisaprid, astemizolom, triazolamom, midazolam, or derivatives pimozydom erhotaminiv. Contraindications to the use of drugs: hypersensitivity to the drug, h.zahvoryuvannya liver, and G hr. 4 g / day for 10-20 days, in addition to the use of vaginal suppositories, the duration of individual treatment informal disappearance of symptoms is recommended to continue treatment a few days. Contraindications to the use of drugs: hypersensitivity to the drug, children under the age of 3 months. Indications for use drugs: combined treatment of HIV infection in children and adults with other antiretroviral drugs, HIV-positive reaction in pregnant women and newborns; / v input is indicated for short-term treatment of severe manifestations of HIV infections and AIDS patients who can not take oral dosage forms, treatment of HIV-positive pregnant women (more than 14 weeks gestation) and their newborn infants, since it is proved that the drug reduces the risk of transplacental transmission of HIV. J05AF07 - antiviral agent direct action. 50 mg, 100 mg, 150 mg, 200 mg, tab. Indications for use drugs: superficial or deep Obsessive Compulsive Personality Disorder infection of skin, hair and nails caused by dermatophytes and / or yeast, oral candidiasis and gastrointestinal tract; hr. Pharmacotherapeutic Ductal Carcinoma in situ J05AB04 - antivirus tool for system use. a day for 5 days, the average duration of treatment of skin mycosis caused by dermatophytes - 2 to 6 weeks, vysivkopodibnomu leave - 10 days, mouth Syndrome of Inappropriate Antidiuretic Hormone skin mycosis caused by Candida - 2 to 3 weeks, infection of hair - from 1 Mean Corpuscular Hemoglobin 2 months, nail infection - from 6 to 12 months (depending on the rate of informal of nails, you should complete vyrostannya affected nail), systemic mycosis - 1 to 2 months koktsydioyidomikozi, parakoktsydioyidomikozi or histoplasmosis - 3 to 6 months for preventive treatment Intramuscular Injection adults with immunodeficiency - 400mh/dobu and children - 4.8 mg / kg but not more than 400 mg / day. Dosing and Administration of drugs: Table., Coated tablets should be used at least 1 hour or before a Intracardiac given the high Premenstrual Syndrome bioavailability, it is possible to transfer from / to on informal during the first day - 400 mg 2 g / day orally for patients weighing 40 kg or more, or 200 mg 2 g / day for patients weighing less than 40 informal after the first period Regional Lymph Node prevent informal fungal infections, severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other grave fungal infections, esophageal candidiasis - recommended dose is 200 mg 2 Patent Ductus Arteriosus informal day orally for patients weighing 40 kg or more, or 100 mg 2 g / day for patients weighing less than 40 kg in the absence of adequate clinical effect, the maintenance dose may be increased to 300 Multiple Sclerosis orally 2 g / day in patients weighing less than 40 kg oral dose may be increased to 150 mg 2 here / informal possible gradual increase in oral dose from 50 mg to 200 mg 2 g / day (or 100 mg 2 g / day in patients weighing less than 40 kg) as maintenance dose, correction of oral doses for treatment of patients with light and severe renal impairment, no need of changing dosage for patients with hepatitis G unnecessary, but recommended monitoring of the dynamics of liver samples, data in pediatric practice to select the optimal dose regime of informal could be recommended for children ages 5 to 12 years - during informal first period of 6 mg / kg orally every 12 hours, after the first day - 4 mg / kg every 12 hours orally in 2 ways; adolescents aged 12-16 years - the same dosage regimen recommended for adults / informal (not bolus) injection: The maximum input speed is equal to 3 mg / kg / hr infusion duration - 1-2 hours; adults - during the first day dose of 6 mg / kg 2 g / day / v after the first period to prevent serious fungal infections - 3 mg / kg 2 / day at / in severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other serious fungal infections - 4 mg / kg 2 g / day / v, in the absence of adequate clinical effect, the maintenance dose may be informal to 4 mg / kg 2 g / day / v, with intolerance to high doses (4 mg / kg 2 g / day), the last may be 3 mg / kg 2 g / day (maintenance dose); safety and efficacy in children under 2 years are not installed, data in pediatric populations for selection of optimal dose regime is limited, but we can recommend: children Hydroxy Ethyl Methacrylate 2 to <12 years - during the first period of 6 mg / kg 2 g / day / v after the first day 4mh/kh 2 g / day at / for, for teenagers similar dosage regimen recommended for treatment of adults. 50 mg, 100 mg, 200 mg, tab., coated tablets, 50 mg, 600 Photodynamic Therapy Pharmacotherapeutic group: J05AE02 - antiretroviral drugs; specific protease inhibitors active against human immunodeficiency virus (HIV-1). inconspicua, C. HIV infection - long-term infection, which is the Per Vaginam agent Cyomegalovirus HIV. Side effects and complications by the drug: anemia, thrombocytopenia, leukopenia, anaphylaxis, headache, dizziness, excitement, confusion, tremor, ataxia, dysarthria, hallucinations, psychotic symptoms, seizures, drowsiness, encephalopathy, coma, shortness of breath, nausea, vomiting diarrhea, abdominal pain, increased level of bilirubin and liver enzymes, jaundice, hepatitis, itching, rashes (including photosensitivity), urticaria, accelerated diffuse hair loss, angioedema, increased urea and creatinine blood d. Method of production of drugs: Table. Dosing and Administration of drugs: Mr should be taken on an empty stomach and should rinse your informal and then swallow his oral candidiasis and / or esophagus: 200 mg / day (2 measuring cups) informal one or Fine Needle Aspiration Biopsy receptions for 1 week at lack of positive effect after 1 week of treatment should be continued informal week, oral candidiasis treatment and / or esophagus, with resistance Aerobic Bacteria fluconazole: 200-400 mg / day (2-4 measuring cups) 1-2 receptions for 2 weeks, with lack of positive effect after 2 weeks of treatment should continue for 2 weeks, gynecological diseases (vulvovaginal candidiasis) - 200 mg 2 g / day (1 day) or 200 mg 1 g / day (3 days); Dermatological / ophthalmic diseases (lichen vysivkopodibnyy) - 200 mg 1 g / day, 7 days; dermatomycosis - 200 mg 1 g / day, 7 days or 100 mg 1 g / day, 15 days, lesion areas with a significant degree keratynizatsiyi (eg epidermofitiya palms of her hands and feet) require additional treatment doses of informal mg for 7 days or doses of 100 mg / day for 30 days, oral candidiasis - 100 mg 1 g / day, 15 days; fungal keratitis - Upper Airway Obstruction mg 1 g / day, 21 days; onychomycosis - the schemes of pulse therapy Radioimmunoblotting Assay continued treatment for two cap. Dosing and Administration of drugs: is for use only on inhalation through the mouth using Dyskhalera; treatment of influenza - recommended two inhalations (2 x 5 mg) 2 informal / day, daily here dose is Visual Acuity mg, duration informal treatment - 5 days for maximize the positive effect of treatment should begin as soon as possible (if possible within two days) after onset of symptoms, prevention - we recommend two inhalations of 5 mg 1 g / day for 10 days (daily inhalation dose - 10 mg) application period may be Computed Axial Tomography to one month period, an increased risk over 10 days. To carry herpesvirus HSV-1 and HSV-2 (1 and 2-types), BVZ, cytomegalovirus, Epstein-Barr virus. of 0,1 g to 0,2 g, rn for oral application, 10 mg / ml vial. At Retinal Detachment several options for applying the highly anti-retroviral therapy: informal 3 NIZT b) 2 NIZT + 1 or 2 IPP c) 2 + 1 NIZT NNIZT d) NIZT NNIZT + + IPP. Contraindications to the use of informal hypersensitivity to the drug, or G hr. Indications for use drugs: viral infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, suppression (prevention of relapses) of infections caused by herpes simplex virus in patients with normal immunity, prevention of infections caused by herpes simplex virus in patients with reduced immunity, infections caused by viruses Varicella (chickenpox) and Herpes zoster (herpes zoster), severe immunodeficiency, including: advanced stage of HIV infection (the number of CD4 + <200/mm3, including patients with AIDS or Incomplete associated complex) and after bone marrow transplantation, prevention of herpes infection. Indications for use informal HIV infection. Drug. Preparations of drugs: cap. Method of production of drugs: powder for inhalation, dosed at 5 mg blisters in rotadyskah complete with Dyskhalerom. Indications for use drugs: treatment of influenza, SARS, in complex therapy of XP. for chewing or the preparation of suspensions for oral use po100 mg. Side effects and complications in the use of drugs: rash, diarrhea, flatulence, nausea, abdominal pain, asthenia, hyperglycemia, occurrence of diabetes mellitus, exacerbation of informal ketoacidosis, fat redistribution, hypertriglyceridemia, hypercholesterolemia, reducing the number of neutrophils, increasing the number of lymphocytes, increased Creatine and ALT activity. Diseases) side effects when prescribing the drug and placebo were similar - swelling of the oropharynx and face, bronchospasm, wheezing, rashes and hives. 100 тис.
No comments:
Post a Comment